Specifically, we show that 75 % (67 tumours from 89 patients) of central high grade chondrosarcomas reveal loss or gain (polysomy) of p16/CDKN2A in at least one sample (data generated from both cohorts). This evidence concerns the gene CDKN2A and chondrosarcoma.